Bottom line: Practical notes for teams scaling psychedelic-assisted therapy—operations, outcomes, AI safety, integration, compliance, and policy.
Insights, research, and strategy at the intersection of psychedelic therapy, AI, and blockchain-powered healthcare infrastructure.
HHS and White House signals suggest faster psychedelic access may be coming—but scaling psychedelic-assisted therapy on retrofit outpatient tools hits predictable walls. Here is why clinic readiness is operational, what failure modes look like at volume, and how Synergy is built for the pathway—not the 50-minute hour—with the Synergy App for patient integration.
AI should not replace therapists. It should reduce note burden, surface contraindication risk, and support proactive follow-up so clinicians can stay present for psychedelic-assisted therapy.
The 50-minute hour doesn’t map to six- to ten-hour medicine sessions. Here’s how high-fidelity documentation, staffing handoffs, touch-contract logging, wearable-aware safety, and integration synthesis fit together—without breaking the container of care.
A perfect storm in mental health, the human toll on youth and veterans, and a 2026 policy shift toward supervised access. Why psychedelic-assisted therapy is framed as structural repair—not another bucket—and how Synergy App is built for the voyage after the drydock.
Durable change depends on preparation, the neuroplastic window, and structured integration—not disconnected visits. Here’s how Synergy’s patient-directed, team-coordinated model runs the program layer generic EHRs were never built for.
Phase 3 trials are moving, targets are diversifying beyond TRD, and dosage, setting, and evidence-grade reporting are becoming baseline. Here’s why the infrastructure moment is now—and how Synergy App is built for both plant and pharmaceutical tracks.
Texas SB 2308 puts ibogaine into an HHSC-led trials framework. The state needs an evidence engine—not spreadsheets. Synergy App is built as Program OS + Reporting Pack for consortium partners and oversight.
Digital twins are the defining healthcare trend of 2026. Here’s how psychedelic clinics can lead with AI-powered, living models that predict risk and personalize care.
The hardware of the mental health revolution has arrived. But the software hasn’t caught up. Here’s why the next wave of psychedelic care depends on purpose-built infrastructure.
Join our newsletter for updates on AI-powered therapy, blockchain compliance, and next-generation patient outcomes.